{"brief_title": "IUdR/BUdR Cell Cycle Labelling", "brief_summary": "To determine cell cycle parameters and changes after treatment, the labelling agent is given and a bone marrow aspiration is accomplished before treatment and after treatment for comparison. Participants must be undergoing concurrent therapy for hematologic malignancy.", "detailed_description": "Cell cycle parameters include LI, Ts, Tc, T dpot, changes in these parameters, and differences between normal and leukemic cells in patients with hematologic malignancy prior to and following treatment.", "condition": "Hematologic Malignancies", "intervention_type": "Drug", "intervention_name": "Chemotherapy for hematologic malignancy", "criteria": "Histologic proof of one of: - AML, ALL, or AUL - MDS or CMML - CML - OR undergoing bone marrow transplantation. Participants should be: - off therapy for at least two weeks - At least 18 years old or older - Using adequate contraception if of child-bearing capability.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00042250.xml"}